Anthrax toxin receptor 2 functions in ecm homeostasis of the murine reproductive tract and promotes MMP activity

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Reeves, Claire V ^a   Wang, Xing ^a   Charles Horvath, Pelisa C ^a   Vink, Joy Y ^a   Borisenko, Valeriya Y ^a   Young, John A T ^b   Kitajewski, Jan K ^a  

^a NewYork Presbyterian Hospital   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN RECEPTOR 1; ANTHRAX TOXIN RECEPTOR 2; CELL PROTEIN; COLLAGEN TYPE 1; COLLAGEN TYPE 6; FIBRONECTIN; GELATINASE A; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; SCLEROPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTRX2 GENE; ARTICLE; CELL DISRUPTION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; FEMALE FERTILITY; FEMALE GENITAL SYSTEM; GENE; HISTOLOGY; IMMUNOBLOTTING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REPRODUCTION; UTERUS MYOMA;

ANIMALS; CELL LINE; COLLAGEN; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; FIBROSIS; HOMEOSTASIS; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MICE; MICE, KNOCKOUT; MYOMETRIUM; NEOVASCULARIZATION, PATHOLOGIC; PARITY; PARTURITION; PROTEIN BINDING; RECEPTORS, PEPTIDE; UTERUS;

MURINAE; MUS;

EID: 84859856438     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034862     Document Type: Article

References (41)

1. Whittaker CA, Hynes RO, (2002) Distribution and evolution of vonWillebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell 13: 3369-3387.
2. Young JA, Collier RJ, (2007) Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu Rev Biochem 76: 243-265.
3. Nanda A, Carson-Walter EB, Seaman S, Barber TD, Stampfl J, et al. (2004) TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI). Cancer Res 64: 817-820.
4. Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, et al. (2005) TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 305: 133-144.
5. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, et al. (2001) Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 114: 2755-2773.
6. Reeves CV, Dufraine J, Young JA, Kitajewski J, (2009) Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis. Oncogene 6: 789-801.
7. Rmali KA, Puntis MC, Jiang WG, (2005) TEM-8 and tubule formation in endothelial cells, its potential role of its vW/TM domains. Biochem Biophys Res Commun 334: 231-238.
8. Dowling O, Difeo A, Ramirez MC, Tukel T, Narla G, et al. (2003) Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73: 957-966.
9. Cullen M, Seaman S, Chaudhary A, Yang MY, Hilton MB, et al. (2009) Host-derived tumor endothelial marker 8 promotes the growth of melanoma. Cancer Res 69: 6021-6026.
10. Stucki U, Spycher MA, Eich G, Rossi A, Sacher P, et al. (2001) Infantile systemic hyalinosis in siblings: clinical report, biochemical and ultrastructural findings, and review of the literature. Am J Med Genet 100: 122-129.
11. Hanks S, Adams S, Douglas J, Arbour L, Atherton DJ, et al. (2003) Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73: 791-800.
12. Tanaka K, Ebihara T, Kusubata M, Adachi E, Arai M, et al. (2009) Abnormal collagen deposition in fibromas from patient with juvenile hyaline fibromatosis. J Dermatol Sci 55: 197-200.
13. Nathanielsz PW, (1978) Endocrine mechanisms of parturition. Annu Rev Physiol 40: 411-445.
14. O'Brien WF, (1995) Cervical ripening and labor induction: progress and challenges. Clin Obstet Gynecol 38: 221-223.
15. Leppert PC, (1995) Anatomy and physiology of cervical ripening. Clin Obstet Gynecol 38: 267-279.
16. Rudolph-Owen LA, Hulboy DL, Wilson CL, Mudgett J, Matrisian LM, (1997) Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice. Endocrinology 138: 4902-4911.
17. Hunt JS, Manning LS, Mitchell D, Selanders JR, Wood GW, (1985) Localization and characterization of macrophages in murine uterus. J Leukoc Biol 38: 255-265.
18. Wood GA, Fata JE, Watson KL, Khokha R, (2007) Circulating hormones and estrous stage predict cellular and stromal remodeling in murine uterus. Reproduction 133: 1035-1044.
19. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R, (2000) Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 57: 77-95.
20. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, et al. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338.
21. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, et al. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
22. Hernandez-Barrantes S, Toth M, Bernardo MM, Yurkova M, Gervasi DC, et al. (2000) Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1 MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation. J Biol Chem 275: 12080-12089.
23. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, et al. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270: 30479-30485.
24. Liu S, Crown D, Miller-Randolph S, Moayeri M, Wang H, et al. (2009) Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo. Proc Natl Acad Sci U S A 106: 12424-12429.
25. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, et al. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446-2451.
26. Overall CM, McQuibban GA, Clark-Lewis I, (2002) Discovery of chemokine substrates for matrix metalloproteinases by exosite scanning: a new tool for degradomics. Biol Chem 383: 1059-1066.
27. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, et al. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 97: 4052-4057.
28. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, et al. (1999) MT1-MMP deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 81-92.
29. Morikawa A, Ohara N, Xu Q, Nakabayashi K, DeManno DA, et al. (2008) Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer. Hum Reprod 23: 944-951.
30. Shynlova O, Oldenhof A, Dorogin A, Xu Q, Mu J, et al. (2006) Myometrial apoptosis: activation of the caspase cascade in the pregnant rat myometrium at midgestation. Biol Reprod 74: 839-849.
31. Burroughs KD, Fuchs-Young R, Davis B, Walker CL, (2000) Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat. Biol Reprod 63: 1322-1330.
32. Lehti K, Allen E, Birkedal-Hansen H, Holmbeck K, Miyake Y, et al. (2005) An MT1 MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature. Genes Dev 19: 979-991.
33. Rossi MJ, Chegini N, Masterson BJ, (1992) Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: their action in smooth muscle cells in vitro. Endocrinology 130: 1716-1727.
34. Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H, (2004) MT1-MMP: a tethered collagenase. J Cell Physiol 200: 11-19.
35. Rozanov DV, Golubkov VS, Strongin AY, (2005) Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin. Int J Biochem Cell Biol 37: 142-154.
36. Scobie HM, Wigelsworth DJ, Marlett JM, Thomas D, Rainey GJ, et al. (2006) Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog 2: e111.
37. Scobie HM, Rainey GJ, Bradley KA, Young JA, (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A 100: 5170-5174.
38. Scobie HM, Thomas D, Marlett JM, Destito G, Wigelsworth DJ, et al. (2005) A soluble receptor decoy protects rats against anthrax lethal toxin challenge. J Infect Dis 192: 1047-1051.
39. Pei D, Weiss SJ, (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix degrading activity. J Biol Chem 271: 9135-9140.
40. Wang X, Yi J, Lei J, Pei D, (1999) Expression, purification and characterization of recombinant mouse MT5-MMP protein products. FEBS Lett 462: 261-266.
41. Wang X, Wilson MJ, Slaton JW, Sinha AA, Ewing SL, et al. (2009) Increased aggressiveness of human prostate PC-3 tumor cells expressing cell surface localized membrane type-1 matrix metalloproteinase (MT1-MMP). J Androl 30: 259-274.